PMID- 19154454 OWN - NLM STAT- MEDLINE DCOM- 20090528 LR - 20101118 IS - 1464-410X (Electronic) IS - 1464-4096 (Linking) VI - 103 IP - 9 DP - 2009 May TI - Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem. PG - 1248-54 LID - 10.1111/j.1464-410X.2008.08287.x [doi] AB - OBJECTIVE: To report our experience of treating bladder and bowel dysfunction in children with myelomeningocele, with simultaneous laparoscopic antegrade continence enema (LACE) and repeated intravesical injection of botulinum toxin-type A (BTX-A). PATIENTS AND METHODS: Six girls and 14 boys (mean age, 8.7 years) with myelomeningocele were included in this study. All patients had received one or two intravesical injection(s) of BTX-A, but had persistent fecal incontinence or constipation despite improved urinary symptoms. We performed a two-port laparoscopic appendicostomy, immediately after repeated intravesical injection of BTX-A, through a V-shaped skin flap at McBurney's point. The stoma was finally covered by a quadrilateral skin flap, using the 'VQ' technique. The degree of urinary incontinence and bowel dysfunction were determined in each patient, and conventional urodynamic studies were performed 4 months after each injection. RESULTS: All patients were followed-up for a mean (range) of 19.1 (14-33) months. Urinary continence improved significantly after the first injection, and remained constant after repeat injections. The maximum detrusor pressure, bladder compliance and capacity improved significantly (P < 0.001) compared with baseline. Interestingly, the simultaneous intravesical BTX-A injection/LACE procedure significantly improved all urodynamic variables compared with the values obtained after the last BTX-A injection alone. The laparoscopic procedure was well tolerated, and 19 (95%) children were nappy-free at the final follow-up. Only two patients had stoma stenosis, and one patient had minor stoma leakage. CONCLUSION: Concomitant repeat intravesical injection of BTX-A and LACE can effectively manage bladder and bowel dysfunction in children with myelomeningocele. The procedure may further contribute to improve bladder urodynamic function, as effective evacuation of the bowel provides more room for bladder distension. FAU - Kajbafzadeh, AbdolMohammad AU - Kajbafzadeh A AD - Paediatric Urology Research Center, Department of Urology, Children's Hospital Medical Center, Tehran University of Medical Sciences, Tehran, Iran. FAU - Mahboubi, Amir Hassan AU - Mahboubi AH FAU - Payabvash, Seyedmehdi AU - Payabvash S LA - eng PT - Journal Article DEP - 20081222 PL - England TA - BJU Int JT - BJU international JID - 100886721 RN - 0 (Neuromuscular Agents) RN - EC 3.4.24.69 (Botulinum Toxins, Type A) SB - IM MH - Administration, Intravesical MH - Adolescent MH - Botulinum Toxins, Type A/*administration & dosage MH - Child MH - Child, Preschool MH - Enema/*methods MH - Fecal Incontinence/complications/*therapy MH - Female MH - Follow-Up Studies MH - Humans MH - *Laparoscopy MH - Male MH - Meningomyelocele/complications/*therapy MH - Neuromuscular Agents/*administration & dosage MH - Treatment Outcome MH - Urinary Incontinence/complications/*drug therapy EDAT- 2009/01/22 09:00 MHDA- 2009/05/29 09:00 CRDT- 2009/01/22 09:00 PHST- 2009/01/22 09:00 [entrez] PHST- 2009/01/22 09:00 [pubmed] PHST- 2009/05/29 09:00 [medline] AID - BJU8287 [pii] AID - 10.1111/j.1464-410X.2008.08287.x [doi] PST - ppublish SO - BJU Int. 2009 May;103(9):1248-54. doi: 10.1111/j.1464-410X.2008.08287.x. Epub 2008 Dec 22.